Isoalantolactone Suppresses Glycolysis and Resensitizes Cisplatin-Based Chemotherapy in Cisplatin-Resistant Ovarian Cancer Cells

Cisplatin is a potent chemotherapeutic drug for ovarian cancer (OC) treatment. However, its efficacy is significantly limited due to the development of cisplatin resistance. Although the acquisition of cisplatin resistance is a complex process involving various molecular alterations within cancer ce...

Descripción completa

Detalles Bibliográficos
Autor principal: Chun, Jaemoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419319/
https://www.ncbi.nlm.nih.gov/pubmed/37569773
http://dx.doi.org/10.3390/ijms241512397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419319/
https://www.ncbi.nlm.nih.gov/pubmed/37569773
http://dx.doi.org/10.3390/ijms241512397

Ejemplares similares